Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of prostate cancer: a systematic review and meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2510-3636
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of prostate cancer: a systematic review and meta-analysis ; volume:4 ; number:1 ; day:9 ; month:9 ; year:2020 ; pages:1-15 ; date:12.2020
European journal of hybrid imaging ; 4, Heft 1 (9.9.2020), 1-15, 12.2020
- Creator
-
Woo, Sungmin
Ghafoor, Soleen
Becker, Anton S.
Han, Sangwon
Wibmer, Andreas G.
Hricak, Hedvig
Burger, Irene A.
Schöder, Heiko
Vargas, Hebert Alberto
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s41824-020-00085-9
- URN
-
urn:nbn:de:101:1-2020101419080644364324
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Woo, Sungmin
- Ghafoor, Soleen
- Becker, Anton S.
- Han, Sangwon
- Wibmer, Andreas G.
- Hricak, Hedvig
- Burger, Irene A.
- Schöder, Heiko
- Vargas, Hebert Alberto
- SpringerLink (Online service)
Other Objects (12)
Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in Australia
Inhibitors of the prostate-specific membrane antigen (PSMA) for PET imaging and endoradiotherapy of prostate cancer
Changes in prostate-specific membrane antigen (PSMA) expression following ionizing irradiation - Implications for prostate cancer therapy
Role of Ga68 Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Prostate Cancer Imaging
Heterogeneity of prostate-specific membrane antigen (PSMA) and PSMA-ligand uptake detection combining autoradiography and postoperative pathology in primary prostate cancer
Biomarkers for prostate cancer: prostate-specific antigen and beyond
Prostate-specific membrane antigen (PSMA) radioguided surgery in prostate cancer: An overview of current application and future perspectives
Fluorodeoxyglucose, sodium fluoride, and prostate-specific membrane antigen positron emission tomography studies for treatment response assessment in prostate cancer
Oligometastasis to testis in prostate cancer: Role of gallium-68 prostate-specific membrane antigen positron-emission tomography computed tomography
Extrapleural solitary fibrous tumor evidenced by 68Ga-prostate-specific membrane antigen positron emission tomography/computed tomography study in the staging of a high-risk prostate cancer patient
Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in Australia
Inhibitors of the prostate-specific membrane antigen (PSMA) for PET imaging and endoradiotherapy of prostate cancer
Changes in prostate-specific membrane antigen (PSMA) expression following ionizing irradiation - Implications for prostate cancer therapy
Role of Ga68 Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Prostate Cancer Imaging
Heterogeneity of prostate-specific membrane antigen (PSMA) and PSMA-ligand uptake detection combining autoradiography and postoperative pathology in primary prostate cancer
Biomarkers for prostate cancer: prostate-specific antigen and beyond
Prostate-specific membrane antigen (PSMA) radioguided surgery in prostate cancer: An overview of current application and future perspectives
Fluorodeoxyglucose, sodium fluoride, and prostate-specific membrane antigen positron emission tomography studies for treatment response assessment in prostate cancer
Oligometastasis to testis in prostate cancer: Role of gallium-68 prostate-specific membrane antigen positron-emission tomography computed tomography
Extrapleural solitary fibrous tumor evidenced by 68Ga-prostate-specific membrane antigen positron emission tomography/computed tomography study in the staging of a high-risk prostate cancer patient
Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in Australia
Inhibitors of the prostate-specific membrane antigen (PSMA) for PET imaging and endoradiotherapy of prostate cancer
Changes in prostate-specific membrane antigen (PSMA) expression following ionizing irradiation - Implications for prostate cancer therapy
Role of Ga68 Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Prostate Cancer Imaging
Heterogeneity of prostate-specific membrane antigen (PSMA) and PSMA-ligand uptake detection combining autoradiography and postoperative pathology in primary prostate cancer
Biomarkers for prostate cancer: prostate-specific antigen and beyond
Prostate-specific membrane antigen (PSMA) radioguided surgery in prostate cancer: An overview of current application and future perspectives
Fluorodeoxyglucose, sodium fluoride, and prostate-specific membrane antigen positron emission tomography studies for treatment response assessment in prostate cancer
Oligometastasis to testis in prostate cancer: Role of gallium-68 prostate-specific membrane antigen positron-emission tomography computed tomography
Extrapleural solitary fibrous tumor evidenced by 68Ga-prostate-specific membrane antigen positron emission tomography/computed tomography study in the staging of a high-risk prostate cancer patient
Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen